Turn Therapeutics Inc. share price logo

Turn Therapeutics Inc.

NASDAQ: TTRX

Small Cap

$6.79

-0.14

(-2.02%)

as on

Turn Therapeutics Inc. Stock Performance

as on June 30, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.51
    $6.95
    downward going graph

    4.12%

    Downside

    2.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Turn Therapeutics Inc. share price movements today

Previous Close
$6.93
Open
$6.94
Volume
310.8K
Day's Low - High
$6.51 - $6.95

Turn Therapeutics Inc. Historical Returns

1 Month Return
+ 33.27 %
3 Month Return
+ 100.29 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Turn Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Turn Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$206.4M

EPS (TTM)

-0.1

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-129.17%

Turn Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Turn Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$206.4MNANA0.00%NA
BUY$38.7B470.07%NA0.00%NA
BUY$38.9B75.66%73.0312.55%NA
BUY$124.7B149.69%29.1635.51%NA
BUY$66.4B15.92%15.4629.65%0.58%

Indian Investors' Interest in Turn Therapeutics Inc. Stock

Search interest for Turn Therapeutics Inc. Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Turn Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Jun 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
0
-1
EBITDA
0
-1
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
0
-1
Income Tax Expense
-
-
Net Income
0
-1
Net Profit Margin
0.00%
0.00%

Turn Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-2
-1
EBITDA
-2
-1
Interest Expense
-
-
Depreciation
0
0
Income Before Tax
-2
-1
Income Tax Expense
-
-
Net Income
-2
-1
Net Profit Margin
0.00%
0.00%

Turn Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-1
0
0
Operating Cash Flow
0
0
-1
-1
Investing Cash Flow
0
0
0
0
Financing Cash Flow
2
0
3
7
Change in Cash
3
0
1
6

Turn Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-1
-3
Operating Cash Flow
-1
-2
Investing Cash Flow
0
0
Financing Cash Flow
1
6
Change in Cash
0
4

Global Institutional Holdings in Turn Therapeutics Inc.

Funds
Holdings
Bank of America Corp
0.05%
LPL Financial Corp
0.04%
Hodges Capital Management Inc
0.03%
Wells Fargo & Co
0%
Royal Bank of Canada
0%

Insights on Turn Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TTRX stock has moved up by 20.1%

About Turn Therapeutics Inc.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
OrganisationTurn Therapeutics Inc.
Headquarters250 N Westlake Blvd, Westlake Village, CA, United States, 91362
IndustryBiotechnology
CEOMr. Bradley E. Burnam
E-voting on sharesClick here to vote

Key Management of Turn Therapeutics Inc.

Name

Title

Mr. Bradley E. Burnam

Founder, CEO & Director

Mr. Zuraiz Chaudhary

Interim CFO, VP of Finance & Chief Accounting Officer

Dr. Neilesh Shailesh Ghodadra M.D.

Chief Medical Officer & Director

Mohammed Zubair

Controller

FAQs

What is Turn Therapeutics Inc. share price today?

Turn Therapeutics Inc. share price today is $6.79 as on at the close of the market. Turn Therapeutics Inc. share today touched a day high of $6.95 and a low of $6.51.

What is the 52 week high and 52 week low for Turn Therapeutics Inc. share?

Turn Therapeutics Inc. share touched a 52 week high of $0 on and a 52 week low of $0 on . Turn Therapeutics Inc. stock price today i.e. is closed at $6.79,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Turn Therapeutics Inc.'s market capitalisation today?

Turn Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Turn Therapeutics Inc. Stock (TTRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Turn Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Turn Therapeutics Inc. Shares that will get you 0.2209 shares as per Turn Therapeutics Inc. share price of $6.79 per share as on June 30, 2026 at 1:29 am IST.

What is the minimum amount required to buy Turn Therapeutics Inc. Stock (TTRX) from India?

Indian investors can start investing in Turn Therapeutics Inc. (TTRX) shares with as little as ₹94.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.40 in Turn Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Turn Therapeutics Inc. share’s latest price of $6.79 as on June 30, 2026 at 1:29 am IST, you will get 1.4728 shares of Turn Therapeutics Inc.. Learn more about fractional shares .